Kangyuan Biomedical Tech
Latest round
- Angel
Last raised
- Jun 2024
Total raised
- Undisclosed
Investors
- 1
About Kangyuan Biomedical Tech
Founded in 2016 and based in Dalian, China, Kangyuan Biomedical Tech is a biomedical technology company that focuses on the research and development of blood purification adsorption materials. In 2019, the company was approved by the National Development and Reform Commission's Northeast Revitalization Project. In 2021, it established a blood purification adsorption column product testing platform. As of June 2024, Kangyuan Biomedical Tech has 54 employees. Lingyun Jia, the company's founder and chief scientist, is currently the dean of the School of Bioengineering at Dalian University of Technology, chairman of the Blood Purification Materials Branch of the Chinese Society of Biomaterials, etc. The company's main products include cytokine series products and AAV adsorption fillers. AAV adsorption media include AAV broad-spectrum affinity chromatography media, affinity ligand detection kits and AAV capture kits. The company's products are used to treat renal failure, liver failure, and autoimmune diseases. It also provides customized nanobody services. The company’s revenue is generated by providing blood purification adsorbent materials.
Who invested in Kangyuan Biomedical Tech
1 investor across 1 round
See all investors in Kangyuan Biomedical Tech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jun 4, 2024
Amount
Undisclosed
Investors
Questions about Kangyuan Biomedical Tech
Who invested in Kangyuan Biomedical Tech?
Kangyuan Biomedical Tech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kangyuan Biomedical Tech raised?
Kangyuan Biomedical Tech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kangyuan Biomedical Tech last raise money?
Kangyuan Biomedical Tech's most recent round on record is a Angel, in Jun 2024.
What does Kangyuan Biomedical Tech do?
Founded in 2016 and based in Dalian, China, Kangyuan Biomedical Tech is a biomedical technology company that focuses on the research and development of blood purification adsorption materials.
Where is Kangyuan Biomedical Tech headquartered?
Kangyuan Biomedical Tech is headquartered in Dalian, China.
Which VCs invest in companies like Kangyuan Biomedical Tech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Kangyuan Biomedical Tech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Kangyuan Biomedical Tech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.